Cleared Traditional

K243243 - Delphi MCS Electrode Cap

K243243 is an FDA 510(k) clearance for Delphi MCS Electrode Cap, manufactured by Quantalx Neuroscience, Ltd.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K243243 · Quantalx Neuroscience, Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2025
Decision
118d
Days
Class 2
Risk

K243243 is an FDA 510(k) clearance for the Delphi MCS Electrode Cap. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Quantalx Neuroscience, Ltd. (Kfar Sava, IL). The FDA issued a Cleared decision on February 6, 2025 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Quantalx Neuroscience, Ltd. devices

FDA 510(k) Submission Details - K243243

510(k) Number K243243 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2024
Decision Date February 06, 2025
Days to Decision 118 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 148d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

ProMedoss, Inc.
Bosmat Friedman-Cox

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 184
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K243243.
Ceribell Instant EEG Headcap (Small: C251, Medium: C252)
K251381 · Ceribell, Inc. · Oct 2025
Electrotherapy Electrodes
K250841 · Baisheng Medical Co., Ltd. · Aug 2025
IceCap product line
K243788 · Bioserenity Medical Devices Group · Mar 2025
Electrode Pad
K241512 · Shenzhen Deliduo Medical Technology Co.,Ltd · Jan 2025
Wave Electrode (AE02-60)
K242326 · Bionit Labs Srl · Jan 2025
CAIs Sensor (CAIs-001)
K241160 · Brainu Co., Ltd. · Dec 2024